BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23608636)

  • 1. Characterization of dynamics in complex lyophilized formulations: I. Comparison of relaxation times measured by isothermal calorimetry with data estimated from the width of the glass transition temperature region.
    Chieng N; Mizuno M; Pikal M
    Eur J Pharm Biopharm; 2013 Oct; 85(2):189-96. PubMed ID: 23608636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dynamics in complex lyophilized formulations: II. Analysis of density variations in terms of glass dynamics and comparisons with global mobility, fast dynamics, and Positron Annihilation Lifetime Spectroscopy (PALS).
    Chieng N; Cicerone MT; Zhong Q; Liu M; Pikal MJ
    Eur J Pharm Biopharm; 2013 Oct; 85(2):197-206. PubMed ID: 23623797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glassy-state dynamics from the width of the glass transition: results from theoretical simulation of differential scanning calorimetry and comparisons with experiment.
    Pikal MJ; Chang LL; Tang XC
    J Pharm Sci; 2004 Apr; 93(4):981-94. PubMed ID: 14999734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid state chemistry of proteins: I. glass transition behavior in freeze dried disaccharide formulations of human growth hormone (hGH).
    Pikal MJ; Rigsbee DR; Roy ML
    J Pharm Sci; 2007 Oct; 96(10):2765-76. PubMed ID: 17621677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
    Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
    J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry.
    Liu J; Rigsbee DR; Stotz C; Pikal MJ
    J Pharm Sci; 2002 Aug; 91(8):1853-62. PubMed ID: 12115812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glass transition-related changes in molecular mobility below glass transition temperature of freeze-dried formulations, as measured by dielectric spectroscopy and solid state nuclear magnetic resonance.
    Yoshioka S; Aso Y
    J Pharm Sci; 2005 Feb; 94(2):275-87. PubMed ID: 15570601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Considerations for Determination of Glass Transition Temperature of a Maximally Freeze Concentrated Solution.
    Pansare SK; Patel SM
    AAPS PharmSciTech; 2016 Aug; 17(4):805-19. PubMed ID: 27193003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glass transition and enthalpy relaxation of amorphous lactose glass.
    Haque MK; Kawai K; Suzuki T
    Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
    Tang XC; Pikal MJ
    Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
    Bhugra C; Shmeis R; Krill SL; Pikal MJ
    Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface.
    Devineni D; Gonschorek C; Cicerone MT; Xu Y; Carpenter JF; Randolph TW
    Eur J Pharm Biopharm; 2014 Oct; 88(2):332-41. PubMed ID: 24859390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
    Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
    J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid state chemistry of proteins: II. The correlation of storage stability of freeze-dried human growth hormone (hGH) with structure and dynamics in the glassy solid.
    Pikal MJ; Rigsbee D; Roy ML; Galreath D; Kovach KJ; Wang B; Carpenter JF; Cicerone MT
    J Pharm Sci; 2008 Dec; 97(12):5106-21. PubMed ID: 18351639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freeze-Drying Above the Glass Transition Temperature in Amorphous Protein Formulations While Maintaining Product Quality and Improving Process Efficiency.
    Depaz RA; Pansare S; Patel SM
    J Pharm Sci; 2016 Jan; 105(1):40-9. PubMed ID: 26580140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the glass transition of an amorphous drug using modulated DSC.
    Royall PG; Craig DQ; Doherty C
    Pharm Res; 1998 Jul; 15(7):1117-21. PubMed ID: 9688069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.